About
Caranx Medical is a French MedTech company based in Nice, specializing in intelligent, autonomous robotic solutions for complex surgical procedures, particularly in transcatheter heart valve implantation (TAVI). Founded in 2019, the company is led by CEO Philippe Pouletty, CMO Eric Sejor, and CTO Pierre Berthet-Rayne, and employs a team of over 20 experts in various fields, including robotics and artificial intelligence. The company's flagship product, TAVIPILOT, is the first AI software designed for real-time intra-operative guidance during heart valve implantation. This innovative solution is part of a broader robotic system developed on the proprietary AiiR platform, aimed at optimizing aortic valve procedures. Caranx Medical has achieved significant milestones, including the successful completion of the first robotic-assisted aortic valve implantation in an animal model. The company is committed to advancing research and development, with plans for clinical trials starting in 2026, as it seeks to redefine standards in medical interventions through AI and robotic technologies.
Technologies
Keywords
Company Information
-
Employees 26
-
Founded 2020
Location
Nice, Provence-Alpes-Cote d'Azur, France, 06300